menu
    • menu

    Company profile for Virupaksha Organics

    Virupaksha-PSE
    News
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    aTyr Flunks Phase 3 Lung Disease Trial, Deflating Stock

    16 Sep 2025

    // REUTERS

    Corstasis Scores FDA Nod for Nasal Spray Treatment

    16 Sep 2025

    // FIERCE PHARMA

    DATA COMPILATION
    #PharmaFlow

    Virupaksha Organics

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #11.0F34

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://www.pharmacompass.com/video-supplier-spotlight/virupaksha-organics/corporate-video

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    With Virupaksha, you get a quality product with on-time delivery.

    Related CompaniesRelated Companies

    About

    Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the Hyderabad-based company has grown from a single manufacturing unit to four, employing over 1,000 people. The manufacturing units are situated in Kazipally, Pashamylaram, Humnabad and Gandhi Nagar. Virupaksha's manufacturing facility holds FDA approval, reflecting its adherence to stringent standards. With a customer base exceeding 300 and a presence spanning over 70 countries, Virupaksha has established itself as a reputable global player in its field.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Virupaksha Organicsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    IDA Industrial Area, Hyderabad Telangana, 500037
    Telephone
    Telephone
    +91 4023075816
    Client Email
    Email
    info@virupaksha.com
    Client Website
    Website
    https://virupaksha.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/virupaksha-organics-limited
    youtube
    YouTube
    https://www.youtube.com/channel/UCJC8cgBXIDFtn-4mcoJYkMA
    Twitter
    Twitter
    https://x.com/Virupaksha_hybd
    Contact Info
    Others

    Unit 1
    Sy.No.10, Gaddapotharam village, Jinnaram Mandal, Sangareddy Dist., Telangana, India

    Unit 2
    Plot no 30 to 33 IDA Pashamylaram Patancheru,Sangareddy Dist., Telangana, India

    Unit 3
    Plot no 100 (P2) & 100 (P3),Gadwanthi vil, Humnabad, Bidar, Karnataka, India

    KLPL
    Plot no 106(B)&107, Gadwanthi vil, Humnabad, Bidar, Karnataka, India

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI WW Frankfurt

    Booth #11.0F34

    envelop Contact Supplier

    CPhI WW Frankfurt

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/virupaksha-organics-party-content-16798.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/virupaksha-organics-party-content-27692.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/virupaksha-organics-party-content-35574.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/virupaksha-organics-party-content-59652.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Intermediates Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/virupaksha-organics-party-content-48825.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 14314

    https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

    #PharmaFlow by PHARMACOMPASS
    21 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    https://www.bseindia.com/xml-data/corpfiling/AttachHis/1C45CF51-65B3-4DE7-B64C-CE5E996BBAD7-191527.pdf

    BSEINDIA
    30 Sep 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    2-(2,4-difluorphenyl)-1.3-bis(1h-1,2...

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 38391

    Submission : 2023-06-16

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Bilastine

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 38752

    Submission : 2024-02-14

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Citalopram Hydrobromide

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2024-12-17

    Pay. Date : 2023-06-05

    DMF Number : 36925

    Submission : 2023-05-22

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Crisaborole

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2019-11-05

    Pay. Date : 2019-10-18

    DMF Number : 33275

    Submission : 2018-10-17

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Dextromethorphan Hydrobromide

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2024-08-23

    Pay. Date : 2024-08-19

    DMF Number : 39295

    Submission : 2024-01-23

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Efinaconazole

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2018-06-28

    Pay. Date : 2018-05-11

    DMF Number : 31366

    Submission : 2017-01-19

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Escitalopram Oxalate

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2022-05-17

    Pay. Date : 2022-04-13

    DMF Number : 36632

    Submission : 2022-01-06

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Fexofenadine Hcl (form-1) Usp

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2014-07-15

    Pay. Date : 2014-06-27

    DMF Number : 23070

    Submission : 2009-08-10

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Fluconazole Usp

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-09-04

    Pay. Date : 2015-04-30

    DMF Number : 24437

    Submission : 2010-12-10

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Tramadol Hydrochloride

    India
    arrow
    CPhI WW Frankfurt
    Booth #11.0F34
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

    Virupaksha Organics

    GDUFA

    DMF Review : Complete

    Rev. Date : 2018-08-01

    Pay. Date : 2018-02-20

    DMF Number : 30504

    Submission : 2016-04-22

    Status : Active

    Type : II

    Virupaksha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    REF. STANDARDS & IMPURITIES

    Check the ref. standards & impurities from this company

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Virupaksha Organics and get a quotation

    Virupaksha Organics is a supplier offers 34 products (APIs, Excipients or Intermediates).

    Find a price of Fexofenadine Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Virupaksha Organics

    Find a price of Fluconazole bulk with DMF, CEP, JDMF offered by Virupaksha Organics

    Find a price of Tramadol Hydrochloride bulk with DMF, CEP, WC offered by Virupaksha Organics

    Find a price of Escitalopram Oxalate bulk with DMF, CEP offered by Virupaksha Organics

    Find a price of Bilastine bulk with DMF, JDMF offered by Virupaksha Organics

    Find a price of Citalopram Hydrobromide bulk with DMF, CEP offered by Virupaksha Organics

    Find a price of Tapentadol bulk with CEP, WC offered by Virupaksha Organics

    Find a price of Crisaborole bulk with DMF offered by Virupaksha Organics

    Find a price of Fexofenadine Hydrochloride bulk with JDMF offered by Virupaksha Organics

    Find a price of Dextromethorphan Hydrobromide bulk with DMF offered by Virupaksha Organics

    Find a price of Efinaconazole bulk with DMF offered by Virupaksha Organics

    Find a price of Fluconazole bulk with DMF offered by Virupaksha Organics

    Find a price of 1-(4-(BENZYLOXY)-3-(HYDROXYMETHYL)PHENYL)-2-(TERT-BUTYLAMINO) ETHAN-1-OL bulk with DMF offered by Virupaksha Organics

    Find a price of Tramadol Hydrochloride bulk offered by Virupaksha Organics

    Find a price of Bempedoic Acid bulk offered by Virupaksha Organics

    Find a price of Chlorthalidone bulk offered by Virupaksha Organics

    Find a price of Clopidogrel bulk offered by Virupaksha Organics

    Find a price of Efinaconazole bulk offered by Virupaksha Organics

    Find a price of Etoricoxib bulk offered by Virupaksha Organics

    Find a price of Fluconazole bulk offered by Virupaksha Organics

    Find a price of Flurbiprofen bulk offered by Virupaksha Organics

    Find a price of Imeglimin Hydrochloride bulk offered by Virupaksha Organics

    Find a price of Isavuconazonium Sulfate bulk offered by Virupaksha Organics

    Find a price of Lacosamide bulk offered by Virupaksha Organics

    Find a price of Linagliptin bulk offered by Virupaksha Organics

    Find a price of Lurasidone Hydrochloride bulk offered by Virupaksha Organics

    Find a price of Ranolazine bulk offered by Virupaksha Organics

    Find a price of Sacubitril-Valsartan bulk offered by Virupaksha Organics

    Find a price of Salbutamol Sulphate bulk offered by Virupaksha Organics

    Find a price of Tafamidis bulk offered by Virupaksha Organics

    Find a price of Tafamidis Meglumine bulk offered by Virupaksha Organics

    Find a price of Tavaborole bulk offered by Virupaksha Organics

    Find a price of Vildagliptin bulk offered by Virupaksha Organics

    Find a price of Vonoprazan Fumarate bulk offered by Virupaksha Organics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search